Literature DB >> 8712068

The role of the insulin-like growth factor system in human cancer.

H Werner1, D LeRoith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712068     DOI: 10.1016/s0065-230x(08)60354-1

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  59 in total

Review 1.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

Review 2.  Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer.

Authors:  Bénédicte Fauvel; Aziz Yasri
Journal:  MAbs       Date:  2014-05-14       Impact factor: 5.857

3.  Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.

Authors:  Yi Peter Hu; Sandip B Patil; Michelle Panasiewicz; Wenhui Li; Jennie Hauser; Lisa E Humphrey; Michael G Brattain
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

4.  Solitary fibrous tumour of the liver with IGF-II-related hypoglycaemia. A case report.

Authors:  F Famà; Yves Le Bouc; G Barrande; A Villeneuve; M G Berry; R R Pidoto; O Saint Marc
Journal:  Langenbecks Arch Surg       Date:  2008-04-17       Impact factor: 3.445

5.  Type I insulin-like growth factor receptor induces pulmonary tumorigenesis.

Authors:  Nicolle M Linnerth; Megan D Siwicky; Craig I Campbell; Katrina L M Watson; James J Petrik; Jeffrey A Whitsett; Roger A Moorehead
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

6.  Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequences.

Authors:  Doron Amit; Sagi Tamir; Abraham Hochberg
Journal:  Int J Clin Exp Med       Date:  2013-01-26

7.  Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation.

Authors:  Liang-Hui Shi; Xiao-Qun Zhu; Guo-Hai Zhao; Ya-Bin Xia; Yi-Sheng Zhang
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

8.  Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.

Authors:  W Kalus; M Zweckstetter; C Renner; Y Sanchez; J Georgescu; M Grol; D Demuth; R Schumacher; C Dony; K Lang; T A Holak
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

9.  Nutrient pathways and breast cancer risk: the Long Island Breast Cancer Study Project.

Authors:  Patrick T Bradshaw; Nikhil K Khankari; Susan L Teitelbaum; Xinran Xu; Brian N Fink; Susan E Steck; Mia M Gaudet; Geoffrey C Kabat; Mary S Wolff; Alfred I Neugut; Jia Chen; Marilie D Gammon
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

10.  Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.

Authors:  Celia A Kanashiro; Andrew V Schally; Kate Groot; Patricia Armatis; Andrea L F Bernardino; Jozsef L Varga
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.